Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 49

1.

Moderate risk-adapted dose escalation with three-dimensional conformal radiotherapy of localized prostate cancer from 70 to 74 Gy. First report on 5-year morbidity and biochemical control from a prospective Austrian-German multicenter phase II trial.

Goldner G, Bombosch V, Geinitz H, Becker G, Wachter S, Glocker S, Zimmermann F, Wachter-Gerstner N, Schrott A, Bamberg M, Molls M, Feldmann H, Pötter R.

Strahlenther Onkol. 2009 Feb;185(2):94-100. doi: 10.1007/s00066-009-1970-3. Epub 2009 Feb 25.

PMID:
19240995
2.

The use of conformal radiotherapy and the selection of radiation dose in T1 or T2 low or intermediate risk prostate cancer - a systematic review.

Brundage M, Lukka H, Crook J, Warde P, Bauman G, Catton C, Markman BR, Charette M; Cancer Care Ontario Practice Guidelines Initiative Genitourinary Cancer Disease Site Group.

Radiother Oncol. 2002 Sep;64(3):239-50. Review.

PMID:
12242112
3.

Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.

Vargas C, Martinez A, Kestin LL, Yan D, Grills I, Brabbins DS, Lockman DM, Liang J, Gustafson GS, Chen PY, Vicini FA, Wong JW.

Int J Radiat Oncol Biol Phys. 2005 Aug 1;62(5):1297-308. Review.

PMID:
16029785
4.
5.

Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer.

Leibel SA, Fuks Z, Zelefsky MJ, Hunt M, Burman CM, Mageras GS, Chui CS, Jackson A, Amols HI, Ling CC.

Semin Oncol. 2003 Oct;30(5):596-615. Review.

PMID:
14571409
7.

Systematic review of the effect of radiation dose on tumor control and morbidity in the treatment of prostate cancer by 3D-CRT.

van Tol-Geerdink JJ, Stalmeier PF, Pasker-de Jong PC, Huizenga H, van Lin EN, Schimmel EC, Leer JW, van Daal WA.

Int J Radiat Oncol Biol Phys. 2006 Feb 1;64(2):534-43. Epub 2005 Oct 24. Review.

PMID:
16246497
8.

Higher-than-conventional radiation doses in localized prostate cancer treatment: a meta-analysis of randomized, controlled trials.

Viani GA, Stefano EJ, Afonso SL.

Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1405-18. doi: 10.1016/j.ijrobp.2008.10.091. Review.

PMID:
19616743
9.

[Conformal radiotherapy of prostate cancer].

Hennequin C, Quero L, Soudi H, Sergent G, Maylin C.

Ann Urol (Paris). 2006 Aug;40(4):233-40. Review. French.

PMID:
16970066
10.

Adjuvant radiotherapy for patients with locally advanced prostate cancer--a new standard?

Ganswindt U, Stenzl A, Bamberg M, Belka C.

Eur Urol. 2008 Sep;54(3):528-42. doi: 10.1016/j.eururo.2008.06.059. Epub 2008 Jun 23. Review.

PMID:
18602742
11.

The case for dose escalation versus adjuvant androgen deprivation therapy for intermediate risk prostate cancer.

Pickles T, Pollack A.

Can J Urol. 2006 Apr;13 Suppl 2:68-71. Review.

PMID:
16672133
12.

[pT3R1 prostate cancer : Immediate or delayed radiotherapy after radical prostatectomy?].

Bottke D, Wiegel T.

Urologe A. 2008 Nov;47(11):1431-5. doi: 10.1007/s00120-008-1724-3. Review. German.

PMID:
18810383
13.

Update on the treatment of prostate cancer with external beam irradiation.

Horwitz EM, Hanlon AL, Hanks GE.

Prostate. 1998 Nov 1;37(3):195-206. Review.

PMID:
9792138
14.

[Conformal radiotherapy of prostatic cancer: a general review].

Chauvet B, Oozeer R, Bey P, Pontvert D, Bolla M.

Cancer Radiother. 1999 Sep-Oct;3(5):393-406. Review. French.

PMID:
10572509
15.

Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for non-metastatic prostate cancer.

Jereczek-Fossa BA, Orecchia R.

Radiother Oncol. 2007 Aug;84(2):197-215. Epub 2007 May 29. Review.

PMID:
17532494
16.

[Radiotherapy of prostate carcinoma].

Zimmermann F, Geinitz H, Molls M.

Praxis (Bern 1994). 2001 Sep 20;90(38):1632-40. Review. German.

PMID:
11675916
17.

Percutaneous radiotherapy for low-risk prostate cancer: options for 2007.

Bottke D, Wiegel T.

World J Urol. 2007 Mar;25(1):53-7. Epub 2007 Feb 15. Review.

PMID:
17364213
18.

70 Gy or more: which dose for which prostate cancer?

Ganswindt U, Paulsen F, Anastasiadis AG, Stenzl A, Bamberg M, Belka C.

J Cancer Res Clin Oncol. 2005 Jul;131(7):407-19. Epub 2005 May 11. Review.

PMID:
15887028
19.

Dose escalation in locally advanced carcinoma of the prostate.

Blanco AI, Michalski JM.

Semin Radiat Oncol. 2003 Apr;13(2):87-97. Review.

PMID:
12728438
20.

Long-term results after external beam radiation therapy for T1-T2 localized prostate cancer.

Lagerveld BW, Laguna MP, de la Rosette JJ.

Curr Urol Rep. 2003 Jun;4(3):240-7. Review.

PMID:
12756089

Supplemental Content

Support Center